Equity Overview
Price & Market Data
Price: $0.0₃7
Daily Change: $0.00 / 0.00%
Range: $0.0₃7 - $0.0₃8
Market Cap: $3,691,002
Volume: 1,895,865
Performance Metrics
1 Week: -12.50%
1 Month: %
3 Months: %
6 Months: -36.36%
1 Year: -73.08%
YTD: -12.50%
Details
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.